Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Randomized Controlled Trial of a Collaborative Care Intervention to Manage Cancer Related Symptoms in Patients Diagnosed With Hepatobiliary Carcinoma

NCT01640522 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.

NCT NCT01640522
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01640522 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Randomized Controlled Trial of a Collaborative Care Intervention to Manage Cancer Related Symptoms in Patients Diagnosed With Hepatobiliary Carcinoma
Lead sponsor
University of Pittsburgh
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2008
Completion date
December 31, 2014
Enrollment
261 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bile duct cancer, colorectal carcinoma, gallbladder cancer, hepatocellular carcinoma, liver metastases, pancreatic cancer, primary liver cancer